Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel · Delayed Price · Currency is ILS · Price in ILA 350.00
-21.10 (-5.69%)
Oct 30, 2025, 2:27 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 84.44 million as of October 30, 2025. Its market cap has decreased by -27.65% in one year.
Market Cap
84.44M
Enterprise Value
22.63M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
350.00
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 84.44M, a decrease of -77.06%. That is a compound annual growth rate of -19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 84.44M | -9.89% |
| Dec 31, 2024 | 93.71M | -48.18% |
| Dec 29, 2023 | 180.84M | -29.06% |
| Dec 30, 2022 | 254.92M | -28.46% |
| Dec 31, 2021 | 356.33M | -8.65% |
| Dec 31, 2020 | 390.07M | 30.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.29B |
| Danel (Adir Yeoshua) | 3.01B |
| Kamada | 1.34B |
| SofWave Medical | 1.06B |
| BrainsWay | 1.06B |
| Bait Bakfar | 1.05B |
| Ilex Medical | 725.21M |
| Novolog (Pharm-Up 1966) | 662.60M |